tiprankstipranks
Advertisement
Advertisement

HK:6955 Stock Latest News

Shandong Boan Files for Brazil Approval of EYLEA Biosimilar BA9101
Company AnnouncementsShandong Boan Files for Brazil Approval of EYLEA Biosimilar BA9101
6d ago
6955
Shandong Boan Wins CDE Nod for Next-Gen PD-1/IL-2 Cancer Drug BA1203
PremiumCompany Announcements
Shandong Boan Wins CDE Nod for Next-Gen PD-1/IL-2 Cancer Drug BA1203
1M ago
6955
Shandong Boan Wins CDE Nod for Phase II Lung Cancer Trial of Novel Immunotherapy Combo
PremiumCompany Announcements
Shandong Boan Wins CDE Nod for Phase II Lung Cancer Trial of Novel Immunotherapy Combo
1M ago
6955
Shandong Boan Wins Shareholder Backing for All AGM Resolutions and Share Mandates
PremiumCompany Announcements
Shandong Boan Wins Shareholder Backing for All AGM Resolutions and Share Mandates
2M ago
6955
Shandong Boan Licenses Trulicity Biosimilar BA5101 for U.S. Market
PremiumCompany Announcements
Shandong Boan Licenses Trulicity Biosimilar BA5101 for U.S. Market
2M ago
6955
Shandong Boan Files for U.S. Approval of Denosumab Biosimilars as Global Push Accelerates
PremiumCompany AnnouncementsShandong Boan Files for U.S. Approval of Denosumab Biosimilars as Global Push Accelerates
2M ago
6955
Shandong Boan Biotech Sets 2026 AGM With Expanded Share Issuance Mandate on Agenda
Premium
Company Announcements
Shandong Boan Biotech Sets 2026 AGM With Expanded Share Issuance Mandate on Agenda
3M ago
6955
Boan Biotech Wins New China Approval for Denosumab Biosimilar, Accelerates Global Push
Premium
Company Announcements
Boan Biotech Wins New China Approval for Denosumab Biosimilar, Accelerates Global Push
3M ago
6955
Shandong Boan Biotechnology Launches HK$200 Million Share Buyback Plan
PremiumCompany Announcements
Shandong Boan Biotechnology Launches HK$200 Million Share Buyback Plan
3M ago
6955
Shandong Boan Biotechnology Seeks Shareholder Nod for New RSU Incentive Scheme
PremiumCompany Announcements
Shandong Boan Biotechnology Seeks Shareholder Nod for New RSU Incentive Scheme
4M ago
6955
Shandong Boan Gains CDE Nod for Phase II Combo Trial in NSCLC
PremiumCompany Announcements
Shandong Boan Gains CDE Nod for Phase II Combo Trial in NSCLC
4M ago
6955
Shandong Boan Announces Leadership Changes as R&D Chief Retires
PremiumCompany Announcements
Shandong Boan Announces Leadership Changes as R&D Chief Retires
4M ago
6955
Shandong Boan Biotechnology Updates Board and Committee Structure
PremiumCompany AnnouncementsShandong Boan Biotechnology Updates Board and Committee Structure
4M ago
6955
Shandong Boan Boosts 2025 Revenue as Commercial Push Lifts Costs
Premium
Company Announcements
Shandong Boan Boosts 2025 Revenue as Commercial Push Lifts Costs
4M ago
6955
Shandong Boan Biotech Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Shandong Boan Biotech Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
5M ago
6955
Shandong Boan Biotechnology’s Controlling Shareholder to Complete H-Share Transfer
PremiumCompany Announcements
Shandong Boan Biotechnology’s Controlling Shareholder to Complete H-Share Transfer
7M ago
6955
Shandong Boan Biotechnology’s Controlling Shareholder to Transfer 38.5 Million H Shares
PremiumCompany Announcements
Shandong Boan Biotechnology’s Controlling Shareholder to Transfer 38.5 Million H Shares
7M ago
6955
Shandong Boan Enters RMB41.1 Million Sale-and-Leaseback to Strengthen Working Capital
PremiumCompany Announcements
Shandong Boan Enters RMB41.1 Million Sale-and-Leaseback to Strengthen Working Capital
7M ago
6955
Boan Biotech Explains Trading Surge as Share Transfer and Wins Bolivia Nod for Denosumab Biosimilar
PremiumCompany Announcements
Boan Biotech Explains Trading Surge as Share Transfer and Wins Bolivia Nod for Denosumab Biosimilar
7M ago
6955
Shandong Boan’s Boyoujing® Gains Marketing Approval in China
PremiumCompany AnnouncementsShandong Boan’s Boyoujing® Gains Marketing Approval in China
9M ago
6955
Shandong Boan’s Denosumab Injections Gain UK Regulatory Acceptance
Premium
Company Announcements
Shandong Boan’s Denosumab Injections Gain UK Regulatory Acceptance
9M ago
6955
Shandong Boan Completes Phase III Trial Enrollment for Nivolumab Biosimilar in China
Premium
Company Announcements
Shandong Boan Completes Phase III Trial Enrollment for Nivolumab Biosimilar in China
10M ago
6955

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >